Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 11/20 | 0.72 |
| ▸ | CA12 | O43570 | 10/20 | 0.72 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.72 |
| ▸ | CA1 | P00915 | 6/20 | 0.72 |
| ▸ | AKR1B1 | P15121 | 5/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | HPGD | P15428 | 4/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.72 |
| ▸ | GLA | P06280 | 4/20 | 0.72 |
| ▸ | GAA | P10253 | 4/20 | 0.72 |
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.72 |
| ▸ | CASP1 | P29466 | 3/20 | 0.72 |
| ▸ | CASP7 | P55210 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | CA7 | P43166 | 4/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Umbelliferone SCHEMBL2246676 | 0.89 | CA9 (0.85) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL11137587 | 0.85 | CA9 (1.00) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL29396070 | 0.85 | CA9 (1.00) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL29624448 | 0.85 | CA9 (1.00) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL22018 | 0.85 | CA9 (1.00) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL307982 | 0.83 | CA9 (0.96) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL27427599 | 0.83 | CA9 (0.96) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL27700116 | 0.83 | CA9 (0.96) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL2767044 | 0.83 | CA9 (0.96) | CA9CA12MCL1CA1AKR1B1 | |
| Umbelliferone SCHEMBL27915972 | 0.83 | CA9 (0.96) | CA9CA12MCL1CA1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0452330-A4 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | — | 1992-10-14 | — | — | EP | claimed |
| EP-0452330-A1 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | TOTEM HEALTH SCIENCES, INC. (CA) | 1991-10-23 | — | — | EP | claimed |
| WO-1990004644-A1 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | TOTEM HEALTH SCIENCES, INC. (CA) | 1990-05-03 | — | — | WO | claimed |
| CN-113631572-A | GRP78 and/or HSP70 inhibitors for therapeutic use | GHP科学有限公司 | 2021-11-09 | — | — | CN | disclosed |
| US-8481678-B2 | Peptide-based tooth whitening reagents | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-07-09 | — | — | US | disclosed |
| US-8354381-B2 | Peptide compositions for oral care systems | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-15 | — | — | US | disclosed |
| CN-102770208-A | Living organism load detection using microparticles | 3M INNOVATIVE PROPERTIES CO | 2012-11-07 | — | — | CN | disclosed |
| EP-2413948-A2 | PEPTIDE COMPOSITIONS FOR ORAL CARE SYSTEMS | E. I. du Pont de Nemours and Company (US) | 2012-02-08 | — | — | EP | disclosed |
| CN-102325596-A | Living organism load detection using microparticles | 3M INNOVATIVE PROPERTIES CO | 2012-01-18 | — | — | CN | disclosed |
| US-20100311641-A1 | PEPTIDE-BASED BODY SURFACE COLORING REAGENTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| WO-2010117753-A2 | PEPTIDE COMPOSITIONS FOR ORAL CARE SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-10-14 | — | — | WO | disclosed |
| US-6232095-B1 | KIT FOR DETECTING MISMATCHES AND MUTANTS; CANCER DIAGNOSIS | THOMAS JEFFERSON UNIVERSITY | 2001-05-15 | — | — | US | disclosed |
| US-5736334-A | AMPLIFICATION BY DNA HYDRIDIZATION | ABBOTT LABORATORIES (US) | 1998-04-07 | — | — | US | disclosed |
| EP-0785996-A1 | NUCLEOTIDE SEQUENCES AND PROCESS FOR AMPLIFYING AND DETECTION OF HEPATITIS B VIRUS | ABBOTT LABORATORIES (US) | 1997-07-30 | — | — | EP | disclosed |
| EP-0785996-A4 | — | — | 1997-07-30 | — | — | EP | disclosed |
| WO-1995002690-A1 | NUCLEOTIDE SEQUENCES AND PROCESS FOR AMPLIFYING AND DETECTION OF HEPATITIS B VIRUS | ABBOTT LABORATORIES (US) | 1995-01-26 | — | — | WO | disclosed |
| US-5250412-A | Swab device and method for collecting and analyzing a sample | DIAMEDIX CORPORATION (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0452330-A4 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | — | 1992-10-14 | — | — | EP | disclosed |
| EP-0452330-A1 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | TOTEM HEALTH SCIENCES, INC. (CA) | 1991-10-23 | — | — | EP | disclosed |
| WO-1990004644-A1 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | TOTEM HEALTH SCIENCES, INC. (CA) | 1990-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311641-A1 | PEPTIDE-BASED BODY SURFACE COLORING REAGENTS | CUTA, PRAP1, RBP1 | CA9 3812/4885CA12 1520/4885MCL1 980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.